New study presented at the AATS 98th Annual Meeting shows that patients with malignant lymph nodes following this therapy were less likely to survive than patients who had no cancer in their lymph nodes
https://www.eurekalert.org/pub_releases/2018-05/aaft-fpw042418.php
For patients with esophageal cancer, status of lymph nodes after preoperative therapy determines survival